Antonios Bayas

University of Augsburg — Germany

Medicine · Health Sciences

33h-index3.5kcitations138works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Sclerosis Research Studies(83), Polyomavirus and related diseases(20), Peripheral Neuropathies and Disorders(18), Immunotherapy and Immune Responses(11), Rheumatoid Arthritis Research and Therapies(7)

Publications134 total

Genetic Risk Variants for Multiple Sclerosis and Other Loci Linked to Intrathecal Immunoglobulin G Synthesis
Neurology Neuroimmunology & Neuroinflammation·2025Open Access
Correction: Outcomes After Decompressive Surgery for Severe Cerebral Venous Sinus Thrombosis Associated or Not Associated with Vaccine-Induced Immune Thrombosis with Thrombocytopenia: A Multicenter Cohort Study
Neurocritical Care·2025Open Access
Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 Disease
JAMA Neurology·2025· 2 citedOpen Access
HLA-A∗03:01 as predictive genetic biomarker for glatiramer acetate treatment response in multiple sclerosis: a retrospective cohort analysis
EBioMedicine·2025· 1 citedOpen Access
Long-term follow-up of patients with non-ischemic cerebral enhancing lesions following endovascular aneurysm treatment: magnetic resonance imaging findings, clinical course, and treatment
Therapeutic Advances in Neurological Disorders·2025Open Access
Affekterkennung auf Basis von EEG-Signalen unter Verwendung künstlicher neuronaler Netze
Klinische Neurophysiologie·2025
Disparities in patient share and characteristics between disease-modifying therapy-treated and -untreated people with multiple sclerosis in Germany: a claims data analysis from 2017 to 2022
Frontiers in Neurology·2025Open Access
Worse recovery from acute attacks and faster disability accumulation highlights the unmet need for improved treatment in patients with late-onset neuromyelitis optica spectrum disorders (COPTER-LO study)
Frontiers in Immunology·2025· 4 citedOpen Access
Cellular and humoral vaccination response under immunotherapies—German consensus on vaccination strategies in neurological autoimmune diseases
Therapeutic Advances in Neurological Disorders·2025Open Access
External validation of a multiple sclerosis treatment decision score using data from the ProVal-MS cohort study
Therapeutic Advances in Neurological Disorders·2025Open Access
Mirror movements in multiple sclerosis -a clinical, electrophysiological, and imaging study
BMC Neurology·2024· 1 citedOpen Access
Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Journal of Neurology·2024· 9 citedOpen Access
Multiple sclerosis endophenotypes identified by high-dimensional blood signatures are associated with distinct disease trajectories
Science Translational Medicine·2024· 35 cited
Prospective study validating a multidimensional treatment decision score predicting the 24-month outcome in untreated patients with clinically isolated syndrome and early relapsing–remitting multiple sclerosis, the ProVal-MS study
Neurological Research and Practice·2024· 7 citedOpen Access
Mirror movements in multiple sclerosis -a clinical, electrophysiological, and imaging study
2024Open Access
18fluorodeoxyglucose PET/CT as possible early diagnostic tool preceding MRI changes in Borna disease virus 1 encephalitis
The Lancet·2024· 2 citedOpen Access
First line treatment with subcutaneous efgartigimod in impending myasthenic crisis: a case report
Therapeutic Advances in Neurological Disorders·2024· 2 citedOpen Access
Complement inhibition in seropositive generalized myasthenia gravis as rescue therapy in impending and effective treatment in frequently recurring impending myasthenic crisis—a case series
Therapeutic Advances in Neurological Disorders·2024· 6 citedOpen Access
Ambulante spezialfachärztliche Versorgung (ASV) für die multiple Sklerose
DGNeurologie·2023· 1 cited
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Journal of Neurology·2023· 180 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

Ralf Gold(23), Tania Kümpfel(19), Brigitte Wildemann(18), Friedemann Paul(18), Sven G. Meuth(18), Bernhard Hemmer(16), Ralf A. Linker(16), Martin Stangel(15), Florian Then Bergh(15), Uwe K. Zettl(15), Felix Luessi(14), Anke Salmen(14), Luisa Klotz(13), Björn Tackenberg(13), Sergiu Groppa(12), Frauke Zipp(12), Achim Berthele(11), Frank Weber(11), Heinz Wiendl(11), Christoph Heesen(11)